Pay attention to the study of Fuchs′s variant iris and ciliary body inflammation

doi:10.3877/cma.j.issn.2095-2007.2017.05.002

Abstract

Abstract:

Fuchs′ HeterochromicIridocyclitis is achronicintraocular inflammatory disease, andthe complications includes cataract and glaucoma.Because of its various clinic features, FHI is easy to be misdiagnosed. The pathogenesis of the disease is unclear, up-to-date study showed that the common clinical symptoms may be caused bydifferentpathogenic mechanisms.This review aims to highlight the clinical features, diagnostic criteria and treatment options ofcomplications.

Key words: Fuchs′ heterochromic iridocyclitis, Epidemiology, Etiology, Clinical characteristics, Treatment

Fei Hong, Dan Zhu, Yong Tao. Pay attention to the study of Fuchs′s variant iris and ciliary body inflammation[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2017, 07(05): 198-202.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2017.05.002

https://zhykyxzz.cma-cmc.com.cn/EN/Y2017/V07/I05/198

References 76

[1]	柳小丽，苏冠方，肖骏. 1215例葡萄膜炎患者葡萄膜炎类型与病因分析探讨[J]. 中华眼底病杂志，2015,31(2):150-153.
[2]	Jones NP. The manchester uveitis clinic: the first 3000 patients－epidemiology and casemix[J]. Ocular Immunology and Inflammation, 2015, 23(2):118-126.
[3]	王毓琴，陆晓雅，王毓林，等. 1155例葡萄膜炎的临床分析[J]. 医学研究杂志，2013,42(7):94-98.
[4]	Tugaltutkun I, Güneytefekli E, Urgancioglu M. Results of interferon－alfa therapy in patients with Behet uveitis[J]. Graefes Archive for Clinical & Experimental Ophthalmology, 2006, 244(12):1692-1695.
[5]	Grégoire MA, Kodjikian L, Varron L, et al. Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center[J]. Ocular Immunology & Inflammation, 2011, 19(4):219-226.
[6]	Arcos EBG, Pedrozaseres M, Silvaortiz JS. Clinical and Epidemiologic characteristics of Fuchs HeterochromicIridocyclitis in Hispanic population[J]. Invest Ophthalmol Vis Sci, 2015, 56(6):5765.
[7]	Accorinti M, Spinucci G, Pirraglia MP, et al. Fuchs′ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis[J]. J Ophthalmol, 2016, 2016(2):1458624.
[8]	Babu K, Adiga M, Govekar SR, et al. Associations of Fuchs heterochromic iridocyclitis in a South Indian patient population[J]. Journal of Ophthalmic Inflammation & Infection, 2013, 3(1):1-5.
[9]	Bawazeer AM. Clinical characteristics of Fuchs′ HeterochromicIridocyclitis in a tertiary medical center in Makkah region of Saudi Arabia: A retrospective study[J]. Journal of Taibah University Medical Sciences, 2014, 9(1):65-68.
[10]	姜雅琴，高婧，黄旭东，等. 双眼原发性视网膜色素变性合并Fuchs虹膜异色性葡萄膜炎一例[J]. 中华眼科杂志，2014,50(11):845-847.
[11]	Vadot E, Billet P, Barth E. Seasonal variations in the incidence of acute anterior uveitis[J]. Bulletin Des Sociétés Dophtalmologie De France, 1987, 87(11):1325-1327.
[12]	Loewenfeld IE, Thompson HS. Fuchs′ heterochromic cyclitis: A critical review of the literature. I. Clinical characteristics of the syndrome[J]. Survey of Ophthalmology, 1973, 17(6):394-457.
[13]	Dernouchamps JP. Evaluation of laboratory tests in uveitis: a study by the International Uveitis Study Group[J]. Bull Soc Belge Ophtalmol, 1988, 229(7):23-28.
[14]	Jones NP, Read AP. Is there a genetic basis for Fuchs′ heterochromic uveitis? Discordance in monozygotic twins[J]. British Journal of Ophthalmology, 1992, 76(1):22-24.
[15]	蒋正轩. IL23R基因多态与Behcet病、Vogt－小柳原田综合征和Fuchs综合征遗传易感性研究[D]. 重庆：重庆医科大学，2011.
[16]	Zhou Q, Kijlstra A, Hou S, et al. Lack of association of miR－146a and Ets－1 gene polymorphisms with Fuchs uveitis syndrome in Chinese Han patients[J]. 2012, 18(45):426-430.
[17]	Li H, Hou S, Du L, et al. Polymorphisms of TNFAIP3 Gene in a Chinese Han Population with Fuchs HeterochromicIridocyclitis[J]. Ophthalmic Genetics, 2014, 35(2):63-67.
[18]	Suzuki J, Goto H, Komase K, et al. Rubella virus as a possible etiological agent of Fuchs heterochromiciridocyclitis[J]. Albrecht Von GraæesArchiv Für Ophthalmologie, 2010, 248(10):1487-1491.
[19]	Berge JCEMT, Daele PLAV, Rothova A. Rubella Virus－associated Anterior Uveitis in a Vaccinated Patient: A Case Report[J]. Ocular Immunology & Inflammation, 2016, 24(1):113-114.
[20]	Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between fuchsheterochromiciridocyclitis and the United States rubella vaccination program[J]. Am J Ophthalmol, 2007, 144(3):424-428.
[21]	Piri N, Asghari H, Kaplan HJ. Fuch'sHeterochromicIridocyclitis in Iran: Is the Disease Going to Fade Away？[J]. J Ophthal Vis Res, 2015, 10(3):353-354.
[22]	Kreps EO, Derveaux T, Keyser FD, et al. Fuchs′ Uveitis Syndrome: No Longer a Syndrome？[J]. Ocular Immunology and Inflammation, 2016, (3):1-10.
[23]	Woo JH, Lim WK, Ho SL, et al. Characteristics of cytomegalovirus uveitis in immunocompetent patients[J]. Ocular Immunology and Inflammation, 2015, 23(5):378-383.
[24]	Ruokonen PC, Metzner S, Ucer A, et al. Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs′ heterochromic cyclitis[J]. Graefes Archive for Clinical & Experimental Ophthalmology, 2010, 248(4):565-571.
[25]	Mahendradas P, Shetty R, Malathi J, et al. Chikungunya virus iridocyclitis in Fuchs′ heterochromic iridocyclitis[J]. Indian Journal of Ophthalmology, 2010, 58(6):545-547.
[26]	Jad A, Céline T, Bahram B, et al. Fuchs′ heterochromiccyclitis: a post－infectious manifestation of ocular toxoplasmosis？[J]. International Ophthalmology, 2013, 33(2):189-194.
[27]	Teyssot N, Cassoux N, Lehoang P, et al. Fuchs heterochromiccyclitis and ocular toxocariasis[J]. Am J Ophthalmol, 2005, 139(5):915-916.
[28]	Murray PI, Hoekzema R, van Haren MA, et al. Aqueous humor interleukin－6 levels in uveitis[J]. Invest Ophthalmol Vis Sci, 1990, 31(5):917-920.
[29]	Saari KM. HLA and Fuch′s heterochromic cyclitis[J]. Acta Ophthalmologica, 2010, 62(Suppl. 165):33-35.
[30]	Labalette P, Caillau D, Grutzmacher C, et al. Highly Focused Clonal Composition of CD8 CD28 T Cellsin Aqueous Humor of Fuchs HeterochromicCyclitis[J]. Experimental Eye Research, 2002, 75(3):317-325.
[31]	Kaori S, Yukihiko S, Mitsuo M, et al. Expression Profile of Intravitreous Cytokines, Chemokines and Growth Factors in Patients with Fuchs HeterochromicIridocyclitis[J]. Case Reports in Ophthalmology, 2010, 1(1):5-13.
[32]	Yang P, Fang W, Jin H, et al. Clinical features of Chinese patients with Fuchs′ syndrome[J]. Ophthalmology, 2006, 113(3):473-480.
[33]	Tugaltutkun I, Aydinakova Y, Güneytefekli E, et al. Referral Patterns, Demographic and Clinical Features, and Visual Prognosis of Turkish Patients with Sarcoid Uveitis[J]. Ocular Immunology & Inflammation, 2007, 15(4):337-343.
[34]	Pivetti－Pezzi P, Accorinti M, Colabelli－Gisoldi RA, et al. Vogt－Koyanagi－Harada disease and HLA type in Italian patients[J]. Am J Ophthalmol, 1996, 122(6):889-891.
[35]	Rodriguez A, Calonge M, Pedrozaseres M, et al. Referral patterns of uveitis in a tertiary eye care center[J]. Arch Ophthalmol, 1996, 114(5):593-599.
[36]	Al－Mansour YS, Al－Rajhi AA, Al－Dhibi H, et al. Clinical features and prognostic factors in Fuchs′ uveitis[J]. International Ophthalmology, 2010, 30(5):501-509.
[37]	Miliboussen I, Gharbi O, Letaief I, et al. Fluffy white iris precipitates in Fuchs uveitis: a new sign for an old disease[J]. International Ophthalmology, 2013, 33(6):733-736.
[38]	Fang W, Zhou H, Yang P, et al. Aqueous flare and cells in Fuchs syndrome[J]. Eye, 2009, 23(1):79-84.
[39]	Szepessy Z, Tóth G, Barsi Á，et al. Anterior Segment Characteristics of Fuchs Uveitis Syndrome[J]. Ocular Immunology & Inflammation, 2016, 24(5):594-598.
[40]	Jones NP. Fuchs′ heterochromic uveitis: an update[J]. Survey of Ophthalmology, 1993, 37(4):253-272.
[41]	Arcos EBG, Bautista VM, Pliegonava SU, et al. Chlamydia sp genotypes associated with inclusion conjunctivitis in patients of an Ophthalmology Center in Mexico City[J]. Invest Ophthalmol Vis Sci, 2016, 57(12):2351.
[42]	Paroli MP, Abbouda A, Restivo L, et al. Juvenile Idiopathic Arthritis－associated Uveitis at an Italian Tertiary Referral Center: Clinical Features and Complications[J]. Ocular Immunology & Inflammation, 2015, 23(1):74-81.
[43]	Srinivasan S, Lyall D, Kiire C. Amsler－Verrey sign during cataract surgery in Fuchs heterochromicuveitis[J]. BMJ Case Reports, 2010, 2010:bcr1120092456.
[44]	Tugaltutkun I, Güneytefekli E, Kamaciduman F, et al. A cross－sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients[J]. Am J Ophthalmol, 2009, 148(4):510-515.
[45]	Akira T, Yujiro F, Yuka M. Two cases of Fuchs heterochromiciridocyclitis with vitreous opacity as the outstanding clinical manifestation[J]. Clinical ophthalmology, 2015, 69(12):1669-1673.
[46]	Faramarzi A, Douzandeh A, Yaseri M. Corneal astigmatism in Fuchs′ Heterochromic Iridocyclitis[J]．Bina Winter, 2010 , 2(59):100-104.
[47]	Faramarzi A, Soheilian M, Jabbarpoor BMH, et al. Corneal astigmatism in unilateral Fuchs heterochromic iridocyclitis[J]. Ocular Immunology and Inflammation, 2011, 19(3):151-155.
[48]	Simoes P, Marques A, Guedes M, et al. Fuchs′ Heterochromic Uveitis: an under diagnosed Entity[J]. EC Ophthalmology, 2015:222-230.
[49]	马翠萍，杨培增，方旺，等. Fuchs综合征的临床特征及漏诊和误诊分析[J]. 中华眼底病杂志，2005,21(6):360-362.
[50]	李贵洲. 32例Fuchs综合征的误诊分析[J]. 福建医药杂志，2013,35(5):50-51.
[51]	江文珊，周和政，陈云辉，等. 伴虹膜异色的青光眼睫状体炎综合征与Fuchs综合征的鉴别诊断[C]. 中华医学会第十四次全国眼科学术大会，重庆：2009.
[52]	Chronopoulos A, Roquelaure D, Souteyrand G, et al. Aqueous humor polymerase chain reaction in uveitis－utility and safety[J]. BMC Ophthalmology, 2016, 16(1):189-196.
[53]	Neamtu VA, Kowalski RP, Neamtu CR, et al. The Use of Polymerase Chain Reaction from Anterior Chamber Paracentesis Samples in the Diagnosis of Suspected Infectious Posterior Uveitis[J]. Invest Ophthalmol Vis Sci, 2014, 55(13):5292.
[54]	Groot－Mijnes JDFD, Rothova A, Kijlstra A. Serology, Anterior Chamber and Vitreous Diagnostics[M]. Berlin: Springer Heidelberg, 2016: 149-158.
[55]	Keyhani MD, Ahmadieh H. Analysis of Aqueous Humor and Serum for Rapid Diagnosis of Ocular Toxoplasmosis by Enzyme Linked Zmmuno Sorbent Assay (ELISA) LasserNephelometry (LN)[J]. Trauma Monthly, 2017,6(3):201-206.
[56]	Monica D, Gary F, Wendy M. et al. Clinical Utility of Polymerase Chain Reaction of Ocular Fluid in Uveitis Patients[J]．Invest Ophthalmol Vis Sci, 2012,53(14):3208.
[57]	Zhang L, Yang X, Zheng Q, et al. Binocular indirect ophthalmo microscope－assistant gas－perfused pars plana vitrectomy: A novel technique for vitreous sample acquisition[J]. Medicine, 2016, 95(49):e5503.
[58]	Oahalou A, Schellekens PA, de Groot－Mijnes JD, et al. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause[J]. Retina, 2014, 34(1):108-114.
[59]	Bouchenaki N, Herbort CP. Fluorescein angiographic findings and clinical features in Fuchs′ uveitis[J]. International Ophthalmology, 2010, 30(5):511-519.
[60]	Solis C, Voorduin S, Martinez F. Anterior Segment Fluorescein Angiography Findings in Patients with Fuchs′ Heterochromic Iridocyclitis compared with Normal Subjects[J]. Invest Ophthalmol Vis Sci，2013, 54(15):3579.
[61]	Liu Q, Jia Y, Zhang S, et al. Iris autofluorescence in Fuchs′ heterochromic uveitis[J]. Bri J Ophthalmol, 2016, 100(10):1397-1402.
[62]	Cerquaglia A, Iaccheri B, Fiore T, et al. Full－thickness choroidal thinning as a feature of Fuchs Uveitis Syndrome: quantitative evaluation of the choroid by Enhanced Depth Imaging Optical Coherence Tomography in a cohort of consecutive patients[J]. Graefes Archive for Clinical & Experimental Ophthalmology, 2016, 254(10):2025-2031.
[63]	Bawazeer A. Phacoemulsification Cataract Extraction in Patients with Fuchs′ Heterochromic Iridocyclitis[J]. Journal of King Abdulaziz University－Medical Sciences, 2013, 20(2):13-21.
[64]	黄晓瑛，赵平，闫志鹏，等. 超声乳化白内障吸除术治疗Fuchs综合征并发白内障的疗效观察[J/CD]. 中华眼科医学杂志：电子版，2013,3(6):335-337.
[65]	Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta－analysis[J]. Am J Ophthalmol, 2014, 158(4):676-692.
[66]	Bhargava R, Kumar P, Sharma SK, et al. Phacoemulsification Versus Manual Small Incision Cataract Surgery in Patients With Fuchs HeterochromicIridocyclitis[J]. The Asia－Pacific Journal of Ophthalmology, 2016, 5(5):330-334.
[67]	Kheirkhah A, Nikdel M, Ghadimi H. Implantation of iris－claw Artisan intraocular lens for aphakia in Fuchs′ heterochromiciridocyclitis[J]. Indian Journal of Ophthalmology, 2014, 62(3):373-374.
[68]	Kaori S, Yukihiko S, Mitsuo M, et al. Expression Profile of Intravitreous Cytokines, Chemokines and Growth Factors in Patients with Fuchs HeterochromicIridocyclitis[J]. Case Reports in Ophthalmology, 2010, 1(1):5-13.
[69]	Mehta S, Kempen JH. Cataract surgery in patients with uveitis[J]. International Ophthalmology Clinics, 2015, 55(3):133-139.
[70]	Gee SS, Tabbara KF. Extracapsular cataract extraction in Fuchs' heterochromic iridocyclitis[J]. Am J Ophthalmol, 1989, 108(3):310-314.
[71]	Waters FM, Goodall K, Jones NP, et al. Vitrectomy for vitreous opacification in Fuchs′ heterochromicuveitis[J]. Eye (London, England), 2000, 14(2):216-218.
[72]	Scott RA, Sullivan PM, Aylward GW, et al. The effect of pars planavitrectomy in the management of Fuchs heterochromiccyclitis[J]. Retina, 2001, 21(4):312-316.
[73]	Toniolo JT, Hall AJ, Smith JG, et al. Risk Factors for Glaucoma in a Cohort of Patients with Fuchs Heterochromic Iridocyclitis[J]. Ocular Immunology & Inflammation, 2016, 24(5):1-7.
[74]	You YA, Wu Y, Hu S. Surgical management of secondary glaucoma in Fuchs′ heterochromiciridocyclitis. Graefe′s Archive for Clinical and Experimental Ophthalmology[J]. Albrecht von Graefes Archivfur Klinische und Experimentelle Ophthalmologie, 2013, 251(7):1785-1790.
[75]	Voykov B, Deuter C, Zierhut M, et al. Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs′ uveitis syndrome？[J]. Graefe′s Archive for Clinical and Experimental Ophthalmology, 2014, 252(3):485-549.
[76]	Escott S, Baker D, Opremcak EM. Combined Pars Plana Vitrectomy with Gas Tamponade and Posterior Glaucoma Tube placement in the Management of Fuchs Heterochromic Iridocyclitis complicated by secondary glaucoma[J]. European Journal of Oncology Nursing, 2014, 14(10):S39.

Please choose a citation manager

Content to export